Symptomatic and Asymptomatic Neurocognitive Impairment, ART Adherence and HIV Control: A 4-Year Observational Study-Reference-Cited by-同舟云学术

Symptomatic and Asymptomatic Neurocognitive Impairment, ART Adherence and HIV Control: A 4-Year Observational Study

Published:2024-07-30 Issue: Volume: Page:
ISSN:1090-7165
Container-title:AIDS and Behavior
language:en
Short-container-title:AIDS Behav

Author:

Trunfio Mattia^ORCID,Vuaran Elisa,Vai Daniela,Quarta Caterina,Di Stefano Alessandro,Imperiale Daniele,Cinnirella Giacoma,Bonora Stefano,Di Perri Giovanni,Letendre Scott L.,Calcagno Andrea

Funder

National Institute of Mental Health

Publisher

Springer Science and Business Media LLC

Link

https://link.springer.com/content/pdf/10.1007/s10461-024-04440-w.pdf

Reference48 articles.

1. Han WM, Law MG, Egger M, Wools-Kaloustian K, Moore R, McGowan C, et al. Global estimates of viral suppression in children and adolescents and adults on antiretroviral therapy adjusted for missing viral load measurements: a multiregional, retrospective cohort study in 31 countries. The Lancet HIV. 2021;8:e766–75.

2. Bezabhe WM, Chalmers L, Bereznicki LR, Peterson GM. Adherence to antiretroviral therapy and virologic failure: a meta-analysis. Medicine. 2016;95:e3361.

3. Crespo-Bermejo C, de Arellano ER, Lara-Aguilar V, Valle-Millares D, Gómez-Lus ML, Madrid R, et al. Persistent low-level viremia in persons living with HIV undertreatment: an unresolved status. Virulence. 2021;12:2919–31.

4. Younas M, Psomas C, Reynes C, Cezar R, Kundura L, Portalès P, et al. Residual viremia is linked to a specific immune activation profile in HIV-1-Infected adults under efficient antiretroviral therapy. Front immunol. 2021;12:663843.

5. Miller LG, Golin CE, Liu H, Hays RD, Hua J, Wenger NS, et al. No evidence of an association between transient HIV viremia (“Blips”) and lower adherence to the antiretroviral medication regimen. J Infect Dis. 2004;189:1487–96.